

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-linolenic acid metabolic process (GO:0036109) | 4.30643068 |
| 2 | diaphragm development (GO:0060539) | 4.16189195 |
| 3 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 4.08318118 |
| 4 | skeletal muscle organ development (GO:0060538) | 4.03011774 |
| 5 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.92397679 |
| 6 | low-density lipoprotein particle clearance (GO:0034383) | 3.88350385 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.82219846 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 3.82219846 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 3.79351479 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.79351479 |
| 11 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.71011334 |
| 12 | hypotonic response (GO:0006971) | 3.70648840 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 3.68589635 |
| 14 | negative regulation of granulocyte differentiation (GO:0030853) | 3.63379378 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 3.59999380 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.58999063 |
| 17 | activation of MAPKKK activity (GO:0000185) | 3.54663075 |
| 18 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.45330934 |
| 19 | lysine catabolic process (GO:0006554) | 3.44709918 |
| 20 | lysine metabolic process (GO:0006553) | 3.44709918 |
| 21 | fatty acid transmembrane transport (GO:1902001) | 3.42110280 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.40143459 |
| 23 | plasma lipoprotein particle clearance (GO:0034381) | 3.38066179 |
| 24 | negative regulation of vascular permeability (GO:0043116) | 3.36736932 |
| 25 | complement activation, alternative pathway (GO:0006957) | 3.34951842 |
| 26 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.31498441 |
| 27 | regulation of cholesterol homeostasis (GO:2000188) | 3.27041608 |
| 28 | positive regulation of fatty acid oxidation (GO:0046321) | 3.26766266 |
| 29 | carnitine shuttle (GO:0006853) | 3.26563606 |
| 30 | glyoxylate metabolic process (GO:0046487) | 3.25583692 |
| 31 | positive regulation of lipid catabolic process (GO:0050996) | 3.25008591 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.23854597 |
| 33 | protein carboxylation (GO:0018214) | 3.23854597 |
| 34 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.19020621 |
| 35 | cysteine metabolic process (GO:0006534) | 3.15871146 |
| 36 | positive regulation of cell size (GO:0045793) | 3.11715733 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 3.11095313 |
| 38 | regulation of fibrinolysis (GO:0051917) | 3.10012098 |
| 39 | regulation of fatty acid oxidation (GO:0046320) | 3.09466366 |
| 40 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.08440430 |
| 41 | protein heterotrimerization (GO:0070208) | 3.07064417 |
| 42 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.06083483 |
| 43 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.04564391 |
| 44 | regulation of protein activation cascade (GO:2000257) | 3.01961565 |
| 45 | plasma membrane repair (GO:0001778) | 3.01871882 |
| 46 | urea metabolic process (GO:0019627) | 3.00646870 |
| 47 | urea cycle (GO:0000050) | 3.00646870 |
| 48 | positive regulation of receptor recycling (GO:0001921) | 3.00151027 |
| 49 | acetyl-CoA metabolic process (GO:0006084) | 3.00040044 |
| 50 | stress fiber assembly (GO:0043149) | 2.99559171 |
| 51 | aromatic amino acid family catabolic process (GO:0009074) | 2.98645925 |
| 52 | fatty acid beta-oxidation (GO:0006635) | 2.97808565 |
| 53 | 2-oxoglutarate metabolic process (GO:0006103) | 2.96285117 |
| 54 | regulation of early endosome to late endosome transport (GO:2000641) | 2.95292338 |
| 55 | adherens junction assembly (GO:0034333) | 2.92544357 |
| 56 | regulation of complement activation (GO:0030449) | 2.92111082 |
| 57 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.90759186 |
| 58 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.87973131 |
| 59 | aspartate family amino acid catabolic process (GO:0009068) | 2.87146781 |
| 60 | regulation of cholesterol storage (GO:0010885) | 2.81809148 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 2.81568049 |
| 62 | RNA stabilization (GO:0043489) | 2.80758804 |
| 63 | mRNA stabilization (GO:0048255) | 2.80758804 |
| 64 | amino-acid betaine transport (GO:0015838) | 2.80211516 |
| 65 | carnitine transport (GO:0015879) | 2.80211516 |
| 66 | regulation of sequestering of triglyceride (GO:0010889) | 2.79707114 |
| 67 | carnitine transmembrane transport (GO:1902603) | 2.79412184 |
| 68 | cellular protein complex localization (GO:0034629) | 2.78804857 |
| 69 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.78276499 |
| 70 | camera-type eye morphogenesis (GO:0048593) | 2.77818407 |
| 71 | kynurenine metabolic process (GO:0070189) | 2.76922040 |
| 72 | bile acid biosynthetic process (GO:0006699) | 2.75842819 |
| 73 | nitrogen cycle metabolic process (GO:0071941) | 2.75202754 |
| 74 | fatty acid oxidation (GO:0019395) | 2.75151449 |
| 75 | myoblast fusion (GO:0007520) | 2.74828432 |
| 76 | negative regulation of cell size (GO:0045792) | 2.74652952 |
| 77 | phospholipid homeostasis (GO:0055091) | 2.74539800 |
| 78 | skin morphogenesis (GO:0043589) | 2.74175201 |
| 79 | high-density lipoprotein particle remodeling (GO:0034375) | 2.73121380 |
| 80 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.72747405 |
| 81 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.72660457 |
| 82 | apoptotic cell clearance (GO:0043277) | 2.72503292 |
| 83 | negative regulation of cholesterol transport (GO:0032375) | 2.71788770 |
| 84 | negative regulation of sterol transport (GO:0032372) | 2.71788770 |
| 85 | epoxygenase P450 pathway (GO:0019373) | 2.71561479 |
| 86 | lipid oxidation (GO:0034440) | 2.69669519 |
| 87 | fatty acid catabolic process (GO:0009062) | 2.67321072 |
| 88 | response to lipoprotein particle (GO:0055094) | 2.67221190 |
| 89 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.67055824 |
| 90 | 4-hydroxyproline metabolic process (GO:0019471) | 2.66501061 |
| 91 | regulation of extracellular matrix disassembly (GO:0010715) | 2.66072367 |
| 92 | modulation by symbiont of host immune response (GO:0052553) | 2.63689233 |
| 93 | positive regulation by symbiont of host defense response (GO:0052509) | 2.63689233 |
| 94 | modulation by symbiont of host defense response (GO:0052031) | 2.63689233 |
| 95 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.63689233 |
| 96 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.63689233 |
| 97 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.63689233 |
| 98 | cell-substrate adherens junction assembly (GO:0007045) | 2.63673243 |
| 99 | focal adhesion assembly (GO:0048041) | 2.63673243 |
| 100 | regulation of monocyte differentiation (GO:0045655) | 2.63590330 |
| 101 | pyrimidine-containing compound salvage (GO:0008655) | 2.63337980 |
| 102 | pyrimidine nucleoside salvage (GO:0043097) | 2.63337980 |
| 103 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.63033392 |
| 104 | response to nerve growth factor (GO:1990089) | 2.63033392 |
| 105 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.62803253 |
| 106 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.61704771 |
| 107 | homocysteine metabolic process (GO:0050667) | 2.61388410 |
| 108 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.61123553 |
| 109 | modulation by symbiont of host cellular process (GO:0044068) | 2.60817376 |
| 110 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.60590531 |
| 111 | creatine metabolic process (GO:0006600) | 2.59958078 |
| 112 | acylglycerol homeostasis (GO:0055090) | 2.59585138 |
| 113 | triglyceride homeostasis (GO:0070328) | 2.59585138 |
| 114 | ethanol oxidation (GO:0006069) | 2.58619252 |
| 115 | regulation of p38MAPK cascade (GO:1900744) | 2.56082004 |
| 116 | cellular modified amino acid catabolic process (GO:0042219) | 2.55668160 |
| 117 | cellular ketone body metabolic process (GO:0046950) | 2.54919982 |
| 118 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.54314344 |
| 119 | reverse cholesterol transport (GO:0043691) | 2.53765734 |
| 120 | response to mercury ion (GO:0046689) | 2.52797992 |
| 121 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.52781985 |
| 122 | arginine catabolic process (GO:0006527) | 2.52257722 |
| 123 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.51900095 |
| 124 | short-chain fatty acid metabolic process (GO:0046459) | 2.50833545 |
| 125 | monocarboxylic acid catabolic process (GO:0072329) | 2.49743840 |
| 126 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.49362342 |
| 127 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.48368224 |
| 128 | valine metabolic process (GO:0006573) | 2.46770668 |
| 129 | regulation of plasminogen activation (GO:0010755) | 2.46657706 |
| 130 | fibrinolysis (GO:0042730) | 2.45888133 |
| 131 | regulation of lipid catabolic process (GO:0050994) | 2.45499004 |
| 132 | protein localization to endosome (GO:0036010) | 2.44856854 |
| 133 | serine family amino acid catabolic process (GO:0009071) | 2.42155148 |
| 134 | carnitine metabolic process (GO:0009437) | 2.42028515 |
| 135 | acylglycerol catabolic process (GO:0046464) | 2.41133751 |
| 136 | neutral lipid catabolic process (GO:0046461) | 2.41133751 |
| 137 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.40264533 |
| 138 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.39810240 |
| 139 | bile acid metabolic process (GO:0008206) | 2.39515441 |
| 140 | cell-substrate junction assembly (GO:0007044) | 2.38738007 |
| 141 | response to laminar fluid shear stress (GO:0034616) | 2.38652914 |
| 142 | protein-lipid complex assembly (GO:0065005) | 2.38101311 |
| 143 | positive regulation of glycogen metabolic process (GO:0070875) | 2.37564878 |
| 144 | tyrosine metabolic process (GO:0006570) | 2.35784461 |
| 145 | negative regulation of lipid transport (GO:0032369) | 2.35459156 |
| 146 | phospholipid efflux (GO:0033700) | 2.34694825 |
| 147 | nerve growth factor signaling pathway (GO:0038180) | 2.34532729 |
| 148 | positive regulation of lipid storage (GO:0010884) | 2.34321898 |
| 149 | basement membrane organization (GO:0071711) | 2.33732767 |
| 150 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.33307028 |
| 151 | plasma lipoprotein particle remodeling (GO:0034369) | 2.33209807 |
| 152 | protein-lipid complex remodeling (GO:0034368) | 2.33209807 |
| 153 | macromolecular complex remodeling (GO:0034367) | 2.33209807 |
| 154 | regulation of triglyceride metabolic process (GO:0090207) | 2.32734150 |
| 155 | growth hormone receptor signaling pathway (GO:0060396) | 2.32633595 |
| 156 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.32381572 |
| 157 | midgut development (GO:0007494) | 2.32194456 |
| 158 | negative regulation of catenin import into nucleus (GO:0035414) | 2.30844741 |
| 159 | positive regulation of extracellular matrix organization (GO:1903055) | 2.30473635 |
| 160 | modulation by virus of host process (GO:0019054) | 2.30246036 |
| 161 | endocytic recycling (GO:0032456) | 2.30147522 |
| 162 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.29771211 |
| 163 | negative regulation of fatty acid transport (GO:2000192) | 2.27167963 |
| 164 | cortical actin cytoskeleton organization (GO:0030866) | 2.27122652 |
| 165 | semaphorin-plexin signaling pathway (GO:0071526) | 2.26300934 |
| 166 | positive regulation of adherens junction organization (GO:1903393) | 2.24852677 |
| 167 | epithelial cell-cell adhesion (GO:0090136) | 2.24288787 |
| 168 | modulation by virus of host morphology or physiology (GO:0019048) | 2.24146097 |
| 169 | positive regulation of protein export from nucleus (GO:0046827) | 2.24128259 |
| 170 | negative regulation of neurotransmitter transport (GO:0051589) | 2.23262446 |
| 171 | positive regulation of myotube differentiation (GO:0010831) | 2.21996314 |
| 172 | cell-cell junction maintenance (GO:0045217) | 2.21515275 |
| 173 | retrograde transport, endosome to Golgi (GO:0042147) | 2.21365059 |
| 174 | barbed-end actin filament capping (GO:0051016) | 2.20863362 |
| 175 | protein targeting to plasma membrane (GO:0072661) | 2.18550714 |
| 176 | regulation of protein deacetylation (GO:0090311) | 2.18407589 |
| 177 | negative regulation of potassium ion transport (GO:0043267) | 2.14603885 |
| 178 | regulation of peptidyl-threonine phosphorylation (GO:0010799) | 2.14207240 |
| 179 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.12639486 |
| 180 | response to host (GO:0075136) | 2.10215984 |
| 181 | response to host defenses (GO:0052200) | 2.10215984 |
| 182 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.10215984 |
| 183 | negative regulation of glial cell proliferation (GO:0060253) | 2.09318435 |
| 184 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.09105612 |
| 185 | positive regulation of Rap GTPase activity (GO:0032854) | 2.08695147 |
| 186 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.07922753 |
| 187 | negative regulation of protein kinase B signaling (GO:0051898) | 2.07876425 |
| 188 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.07869482 |
| 189 | negative regulation of Ras protein signal transduction (GO:0046580) | 2.07394900 |
| 190 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.06965551 |
| 191 | protein retention in ER lumen (GO:0006621) | 2.06747162 |
| 192 | venous blood vessel morphogenesis (GO:0048845) | 2.06575135 |
| 193 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.06323441 |
| 194 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.05482631 |
| 195 | response to acidic pH (GO:0010447) | 2.02453271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.02342366 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.41670115 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.76830320 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.40975916 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.28070277 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.93615756 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.76123286 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.41213104 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.37804571 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.32546530 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.22511731 |
| 12 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.17041551 |
| 13 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14969572 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.13476539 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02964506 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.93264240 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.84946735 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83059573 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 1.81720530 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76332824 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.73778177 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72066607 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63122484 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.61529665 |
| 25 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.51581194 |
| 26 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.51581194 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46570421 |
| 28 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.45046577 |
| 29 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.45041468 |
| 30 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44633645 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.42901308 |
| 32 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.42607153 |
| 33 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40780194 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40772842 |
| 35 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39907010 |
| 36 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.39781419 |
| 37 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38767911 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38731320 |
| 39 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.36704459 |
| 40 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.33315387 |
| 41 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.31024843 |
| 42 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.30286017 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29659438 |
| 44 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29482211 |
| 45 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29002032 |
| 46 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26856752 |
| 47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.26713856 |
| 48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.26693861 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25850931 |
| 50 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.25537706 |
| 51 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.24272667 |
| 52 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22277988 |
| 53 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.22163589 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22020795 |
| 55 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21218330 |
| 56 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21161951 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20233348 |
| 58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19049774 |
| 59 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.18638437 |
| 60 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17738279 |
| 61 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17042336 |
| 62 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15647002 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15645781 |
| 64 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13997641 |
| 65 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13702019 |
| 66 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13059517 |
| 67 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.12606138 |
| 68 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12245560 |
| 69 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12032039 |
| 70 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11547255 |
| 71 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11079610 |
| 72 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.10939135 |
| 73 | * MAF_26560356_Chip-Seq_TH1_Human | 1.10222968 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.08672345 |
| 75 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.08573194 |
| 76 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08103322 |
| 77 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.07700437 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07171593 |
| 79 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06542789 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05941178 |
| 81 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05851676 |
| 82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05342094 |
| 83 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04647873 |
| 84 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04547195 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03926140 |
| 86 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.02328709 |
| 87 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01597669 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00521703 |
| 89 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99296664 |
| 90 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97844740 |
| 91 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.96678745 |
| 92 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.96132698 |
| 93 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95824725 |
| 94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95610019 |
| 95 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95048188 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94367187 |
| 97 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93281834 |
| 98 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93259220 |
| 99 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93239958 |
| 100 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93108187 |
| 101 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92744563 |
| 102 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92573771 |
| 103 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.91616462 |
| 104 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.90388803 |
| 105 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.90036843 |
| 106 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.89917851 |
| 107 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89620661 |
| 108 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89431898 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88714657 |
| 110 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.88603934 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88500355 |
| 112 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.88333882 |
| 113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86988144 |
| 114 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86289347 |
| 115 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85232217 |
| 116 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84695039 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84221645 |
| 118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83917502 |
| 119 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.83459278 |
| 120 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.83433799 |
| 121 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83248022 |
| 122 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.82983184 |
| 123 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82686934 |
| 124 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.81475578 |
| 125 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81469087 |
| 126 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81293022 |
| 127 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.79161716 |
| 128 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79029630 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78922569 |
| 130 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.78462463 |
| 131 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77790588 |
| 132 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.77619854 |
| 133 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77295916 |
| 134 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.77068169 |
| 135 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.77034876 |
| 136 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.77003933 |
| 137 | P68_20966046_ChIP-Seq_HELA_Human | 0.75783579 |
| 138 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.75505408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.98983013 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.82991264 |
| 3 | MP0000566_synostosis | 3.74008283 |
| 4 | MP0005360_urolithiasis | 3.66078359 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 3.14142349 |
| 6 | MP0005365_abnormal_bile_salt | 2.81206997 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 2.79912860 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.62982845 |
| 9 | MP0004130_abnormal_muscle_cell | 2.48608645 |
| 10 | MP0005670_abnormal_white_adipose | 2.41510937 |
| 11 | MP0009840_abnormal_foam_cell | 2.36680121 |
| 12 | MP0005409_darkened_coat_color | 2.29869227 |
| 13 | MP0003252_abnormal_bile_duct | 2.18896427 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.17445736 |
| 15 | MP0005666_abnormal_adipose_tissue | 2.08660850 |
| 16 | MP0005257_abnormal_intraocular_pressure | 2.06954737 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.05755963 |
| 18 | MP0000751_myopathy | 2.03552625 |
| 19 | MP0005083_abnormal_biliary_tract | 2.02137480 |
| 20 | MP0004185_abnormal_adipocyte_glucose | 1.97729613 |
| 21 | MP0005275_abnormal_skin_tensile | 1.96745927 |
| 22 | MP0005623_abnormal_meninges_morphology | 1.96724725 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.89611253 |
| 24 | MP0004272_abnormal_basement_membrane | 1.81285286 |
| 25 | MP0003436_decreased_susceptibility_to | 1.70652909 |
| 26 | MP0004087_abnormal_muscle_fiber | 1.68343504 |
| 27 | MP0006082_CNS_inflammation | 1.68082761 |
| 28 | MP0004084_abnormal_cardiac_muscle | 1.63720209 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.58524889 |
| 30 | MP0005375_adipose_tissue_phenotype | 1.55468712 |
| 31 | MP0004036_abnormal_muscle_relaxation | 1.52945486 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.49525910 |
| 33 | MP0003279_aneurysm | 1.46705688 |
| 34 | MP0010368_abnormal_lymphatic_system | 1.45682796 |
| 35 | MP0005332_abnormal_amino_acid | 1.43992784 |
| 36 | MP0003828_pulmonary_edema | 1.41822124 |
| 37 | MP0003646_muscle_fatigue | 1.40657759 |
| 38 | MP0008260_abnormal_autophagy | 1.40384889 |
| 39 | MP0000858_altered_metastatic_potential | 1.39672752 |
| 40 | MP0000750_abnormal_muscle_regeneration | 1.38224450 |
| 41 | MP0009053_abnormal_anal_canal | 1.35491051 |
| 42 | MP0003806_abnormal_nucleotide_metabolis | 1.33532830 |
| 43 | MP0005330_cardiomyopathy | 1.33427539 |
| 44 | MP0004858_abnormal_nervous_system | 1.33350776 |
| 45 | MP0000749_muscle_degeneration | 1.31963469 |
| 46 | MP0001666_abnormal_nutrient_absorption | 1.30711444 |
| 47 | MP0010234_abnormal_vibrissa_follicle | 1.29625854 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.29349303 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.28268470 |
| 50 | MP0000733_abnormal_muscle_development | 1.28082277 |
| 51 | MP0000609_abnormal_liver_physiology | 1.28043009 |
| 52 | MP0003075_altered_response_to | 1.25030735 |
| 53 | MP0010630_abnormal_cardiac_muscle | 1.24901906 |
| 54 | MP0003123_paternal_imprinting | 1.24748388 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.24058784 |
| 56 | MP0002269_muscular_atrophy | 1.21915112 |
| 57 | MP0009384_cardiac_valve_regurgitation | 1.20346729 |
| 58 | MP0002971_abnormal_brown_adipose | 1.20011408 |
| 59 | MP0000747_muscle_weakness | 1.19028603 |
| 60 | MP0003283_abnormal_digestive_organ | 1.18784492 |
| 61 | MP0008961_abnormal_basal_metabolism | 1.18437493 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.18142157 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.16695834 |
| 64 | MP0005410_abnormal_fertilization | 1.16611707 |
| 65 | MP0004043_abnormal_pH_regulation | 1.14115687 |
| 66 | MP0005620_abnormal_muscle_contractility | 1.14034923 |
| 67 | MP0000759_abnormal_skeletal_muscle | 1.13757389 |
| 68 | MP0003195_calcinosis | 1.12963748 |
| 69 | MP0001348_abnormal_lacrimal_gland | 1.12526428 |
| 70 | MP0005451_abnormal_body_composition | 1.12250457 |
| 71 | MP0004145_abnormal_muscle_electrophysio | 1.11983018 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.11711226 |
| 73 | MP0000467_abnormal_esophagus_morphology | 1.09663828 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 1.08993600 |
| 75 | MP0003091_abnormal_cell_migration | 1.06146954 |
| 76 | MP0001958_emphysema | 1.05190917 |
| 77 | MP0006138_congestive_heart_failure | 1.01349197 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 1.01136759 |
| 79 | MP0005076_abnormal_cell_differentiation | 1.00945127 |
| 80 | MP0008775_abnormal_heart_ventricle | 1.00027040 |
| 81 | MP0002106_abnormal_muscle_physiology | 0.99408641 |
| 82 | MP0002089_abnormal_postnatal_growth/wei | 0.98536762 |
| 83 | MP0005385_cardiovascular_system_phenoty | 0.98436745 |
| 84 | MP0001544_abnormal_cardiovascular_syste | 0.98436745 |
| 85 | MP0002972_abnormal_cardiac_muscle | 0.98177718 |
| 86 | MP0003303_peritoneal_inflammation | 0.97623535 |
| 87 | MP0003942_abnormal_urinary_system | 0.96070016 |
| 88 | MP0005390_skeleton_phenotype | 0.95410514 |
| 89 | MP0002282_abnormal_trachea_morphology | 0.95295324 |
| 90 | MP0004233_abnormal_muscle_weight | 0.94592769 |
| 91 | MP0002877_abnormal_melanocyte_morpholog | 0.94444664 |
| 92 | MP0002295_abnormal_pulmonary_circulatio | 0.93741166 |
| 93 | MP0003724_increased_susceptibility_to | 0.92490863 |
| 94 | MP0003879_abnormal_hair_cell | 0.91719169 |
| 95 | MP0000003_abnormal_adipose_tissue | 0.91207237 |
| 96 | MP0005503_abnormal_tendon_morphology | 0.89390456 |
| 97 | MP0000767_abnormal_smooth_muscle | 0.89088425 |
| 98 | MP0005023_abnormal_wound_healing | 0.88286389 |
| 99 | MP0004883_abnormal_blood_vessel | 0.87916030 |
| 100 | MP0002234_abnormal_pharynx_morphology | 0.87289730 |
| 101 | MP0002113_abnormal_skeleton_development | 0.86917126 |
| 102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86676421 |
| 103 | MP0004510_myositis | 0.86647654 |
| 104 | MP0004947_skin_inflammation | 0.86600688 |
| 105 | MP0005248_abnormal_Harderian_gland | 0.86468136 |
| 106 | MP0009643_abnormal_urine_homeostasis | 0.85724807 |
| 107 | MP0009278_abnormal_bone_marrow | 0.85513396 |
| 108 | MP0004019_abnormal_vitamin_homeostasis | 0.85178661 |
| 109 | MP0005369_muscle_phenotype | 0.84198790 |
| 110 | MP0002249_abnormal_larynx_morphology | 0.83816358 |
| 111 | MP0003329_amyloid_beta_deposits | 0.83727442 |
| 112 | MP0000604_amyloidosis | 0.83053047 |
| 113 | MP0002896_abnormal_bone_mineralization | 0.82955741 |
| 114 | MP0002108_abnormal_muscle_morphology | 0.82690845 |
| 115 | MP0000537_abnormal_urethra_morphology | 0.81526898 |
| 116 | MP0005334_abnormal_fat_pad | 0.81482518 |
| 117 | MP0005058_abnormal_lysosome_morphology | 0.81360685 |
| 118 | MP0003045_fibrosis | 0.81106009 |
| 119 | MP0002168_other_aberrant_phenotype | 0.80520714 |
| 120 | MP0005164_abnormal_response_to | 0.77967484 |
| 121 | MP0002796_impaired_skin_barrier | 0.77698134 |
| 122 | MP0001915_intracranial_hemorrhage | 0.77522245 |
| 123 | MP0003448_altered_tumor_morphology | 0.76930840 |
| 124 | MP0002128_abnormal_blood_circulation | 0.76818376 |
| 125 | MP0001879_abnormal_lymphatic_vessel | 0.76569295 |
| 126 | MP0009115_abnormal_fat_cell | 0.76485901 |
| 127 | MP0003453_abnormal_keratinocyte_physiol | 0.76173908 |
| 128 | MP0001849_ear_inflammation | 0.75398387 |
| 129 | MP0005508_abnormal_skeleton_morphology | 0.75315144 |
| 130 | MP0000343_altered_response_to | 0.74949244 |
| 131 | MP0002419_abnormal_innate_immunity | 0.74459586 |
| 132 | MP0000534_abnormal_ureter_morphology | 0.74266767 |
| 133 | MP0000685_abnormal_immune_system | 0.74259556 |
| 134 | MP0008874_decreased_physiological_sensi | 0.72513842 |
| 135 | MP0003634_abnormal_glial_cell | 0.72133464 |
| 136 | MP0000678_abnormal_parathyroid_gland | 0.71506728 |
| 137 | MP0001614_abnormal_blood_vessel | 0.71137338 |
| 138 | MP0003183_abnormal_peptide_metabolism | 0.69777292 |
| 139 | MP0005197_abnormal_uvea_morphology | 0.69095844 |
| 140 | MP0003115_abnormal_respiratory_system | 0.68839109 |
| 141 | MP0005166_decreased_susceptibility_to | 0.67720450 |
| 142 | MP0002127_abnormal_cardiovascular_syste | 0.66749308 |
| 143 | MP0002116_abnormal_craniofacial_bone | 0.66532362 |
| 144 | MP0003878_abnormal_ear_physiology | 0.66001668 |
| 145 | MP0005377_hearing/vestibular/ear_phenot | 0.66001668 |
| 146 | MP0000249_abnormal_blood_vessel | 0.65640723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.62867076 |
| 2 | Abnormality of the fingertips (HP:0001211) | 3.88938804 |
| 3 | Xanthomatosis (HP:0000991) | 3.63064918 |
| 4 | Sparse lateral eyebrow (HP:0005338) | 3.53126558 |
| 5 | Hyporeflexia of lower limbs (HP:0002600) | 3.52994904 |
| 6 | Obstructive sleep apnea (HP:0002870) | 3.43841683 |
| 7 | Protrusio acetabuli (HP:0003179) | 3.41897228 |
| 8 | Complement deficiency (HP:0004431) | 3.38776497 |
| 9 | Muscle fiber splitting (HP:0003555) | 3.20566045 |
| 10 | Exercise-induced myalgia (HP:0003738) | 3.15853366 |
| 11 | Increased connective tissue (HP:0009025) | 3.10899039 |
| 12 | Lip pit (HP:0100267) | 3.06956879 |
| 13 | Type 1 muscle fiber predominance (HP:0003803) | 3.05662132 |
| 14 | Broad metatarsal (HP:0001783) | 3.03251191 |
| 15 | Difficulty running (HP:0009046) | 3.01055932 |
| 16 | Premature rupture of membranes (HP:0001788) | 2.99961115 |
| 17 | Myoglobinuria (HP:0002913) | 2.97269316 |
| 18 | Asymmetric septal hypertrophy (HP:0001670) | 2.95006778 |
| 19 | Cerebral aneurysm (HP:0004944) | 2.93246396 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 2.92505551 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.91213977 |
| 22 | Long palpebral fissure (HP:0000637) | 2.87684026 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 2.86093609 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 2.84896567 |
| 25 | Sudden death (HP:0001699) | 2.81317389 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 2.77897239 |
| 27 | Exercise-induced muscle cramps (HP:0003710) | 2.77721464 |
| 28 | Neonatal short-limb short stature (HP:0008921) | 2.76706152 |
| 29 | Anal stenosis (HP:0002025) | 2.70226098 |
| 30 | Ketosis (HP:0001946) | 2.70025964 |
| 31 | Intrahepatic cholestasis (HP:0001406) | 2.68276348 |
| 32 | Dysostosis multiplex (HP:0000943) | 2.67854271 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.64280812 |
| 34 | Mucopolysacchariduria (HP:0008155) | 2.64280812 |
| 35 | Shallow orbits (HP:0000586) | 2.62067612 |
| 36 | Abnormality of complement system (HP:0005339) | 2.61133562 |
| 37 | Difficulty climbing stairs (HP:0003551) | 2.60367847 |
| 38 | Peritonitis (HP:0002586) | 2.58501059 |
| 39 | Asymmetry of the thorax (HP:0001555) | 2.54345017 |
| 40 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.53573190 |
| 41 | Disproportionate tall stature (HP:0001519) | 2.49344670 |
| 42 | Hyperacusis (HP:0010780) | 2.46719204 |
| 43 | Increased variability in muscle fiber diameter (HP:0003557) | 2.46193862 |
| 44 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.45187111 |
| 45 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.45187111 |
| 46 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.45187111 |
| 47 | Abnormality of the Achilles tendon (HP:0005109) | 2.44433289 |
| 48 | Lymphangioma (HP:0100764) | 2.43926856 |
| 49 | Hyperammonemia (HP:0001987) | 2.40769715 |
| 50 | Hypolipoproteinemia (HP:0010981) | 2.39674203 |
| 51 | Myocardial infarction (HP:0001658) | 2.38159296 |
| 52 | Epidermoid cyst (HP:0200040) | 2.35328280 |
| 53 | Mitral valve prolapse (HP:0001634) | 2.32202544 |
| 54 | Blue sclerae (HP:0000592) | 2.31006401 |
| 55 | Vascular tortuosity (HP:0004948) | 2.30118657 |
| 56 | Ketoacidosis (HP:0001993) | 2.29425276 |
| 57 | Hemorrhage of the eye (HP:0011885) | 2.29194259 |
| 58 | Distal upper limb amyotrophy (HP:0007149) | 2.28041418 |
| 59 | Upper limb amyotrophy (HP:0009129) | 2.28041418 |
| 60 | Arterial tortuosity (HP:0005116) | 2.27987490 |
| 61 | Skin nodule (HP:0200036) | 2.27894572 |
| 62 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.27079914 |
| 63 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.26955371 |
| 64 | Hypobetalipoproteinemia (HP:0003563) | 2.26804728 |
| 65 | Broad face (HP:0000283) | 2.26499703 |
| 66 | Ventricular tachycardia (HP:0004756) | 2.22949783 |
| 67 | Polycythemia (HP:0001901) | 2.22826015 |
| 68 | Natal tooth (HP:0000695) | 2.21485532 |
| 69 | Achilles tendon contracture (HP:0001771) | 2.19401824 |
| 70 | Abnormal cartilage morphology (HP:0002763) | 2.18342523 |
| 71 | Genu recurvatum (HP:0002816) | 2.17477977 |
| 72 | Aneurysm (HP:0002617) | 2.17179151 |
| 73 | Turricephaly (HP:0000262) | 2.16592600 |
| 74 | Intestinal fistula (HP:0100819) | 2.16517631 |
| 75 | Back pain (HP:0003418) | 2.15611240 |
| 76 | Esophageal varix (HP:0002040) | 2.13793541 |
| 77 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.13763608 |
| 78 | Spinal rigidity (HP:0003306) | 2.12420365 |
| 79 | Round ear (HP:0100830) | 2.12091131 |
| 80 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.09415810 |
| 81 | Ureteral stenosis (HP:0000071) | 2.07905382 |
| 82 | Hyperglycinuria (HP:0003108) | 2.07878329 |
| 83 | Hypoglycemic coma (HP:0001325) | 2.06239148 |
| 84 | Vertebral compression fractures (HP:0002953) | 2.05128430 |
| 85 | Hypercholesterolemia (HP:0003124) | 2.02873435 |
| 86 | Depressed nasal tip (HP:0000437) | 2.02724877 |
| 87 | Vertebral hypoplasia (HP:0008417) | 2.02576057 |
| 88 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.02576057 |
| 89 | Visceral angiomatosis (HP:0100761) | 2.02412615 |
| 90 | Short 5th finger (HP:0009237) | 2.02099584 |
| 91 | Abnormality of glycine metabolism (HP:0010895) | 2.02042097 |
| 92 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.02042097 |
| 93 | Aortic dissection (HP:0002647) | 2.01408396 |
| 94 | EMG: myopathic abnormalities (HP:0003458) | 2.00664576 |
| 95 | Flat acetabular roof (HP:0003180) | 2.00292655 |
| 96 | Abnormality of the common coagulation pathway (HP:0010990) | 1.99752618 |
| 97 | Mitral regurgitation (HP:0001653) | 1.99477277 |
| 98 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.98223428 |
| 99 | Long toe (HP:0010511) | 1.97531836 |
| 100 | Rhabdomyolysis (HP:0003201) | 1.96354373 |
| 101 | Emphysema (HP:0002097) | 1.95279812 |
| 102 | Ankle contracture (HP:0006466) | 1.94887166 |
| 103 | Aortic aneurysm (HP:0004942) | 1.94285090 |
| 104 | Systemic lupus erythematosus (HP:0002725) | 1.93413456 |
| 105 | Hand muscle atrophy (HP:0009130) | 1.93056753 |
| 106 | Mask-like facies (HP:0000298) | 1.92195947 |
| 107 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.91794797 |
| 108 | Bundle branch block (HP:0011710) | 1.90749856 |
| 109 | Coronal craniosynostosis (HP:0004440) | 1.89894249 |
| 110 | Cervical subluxation (HP:0003308) | 1.89174961 |
| 111 | Hyperglycinemia (HP:0002154) | 1.88720173 |
| 112 | Muscle fiber inclusion bodies (HP:0100299) | 1.86212288 |
| 113 | Buphthalmos (HP:0000557) | 1.86100386 |
| 114 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.85937811 |
| 115 | Atrophic scars (HP:0001075) | 1.84951523 |
| 116 | Ureteral obstruction (HP:0006000) | 1.84792337 |
| 117 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.84619088 |
| 118 | Calf muscle hypertrophy (HP:0008981) | 1.84339754 |
| 119 | Cardiovascular calcification (HP:0011915) | 1.83753823 |
| 120 | Neurofibrillary tangles (HP:0002185) | 1.83632249 |
| 121 | Abnormality of the calf musculature (HP:0001430) | 1.81718530 |
| 122 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.80260439 |
| 123 | Fragile skin (HP:0001030) | 1.80259100 |
| 124 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.80160203 |
| 125 | Nephritis (HP:0000123) | 1.79894641 |
| 126 | Distal lower limb muscle weakness (HP:0009053) | 1.79716787 |
| 127 | Atrioventricular block (HP:0001678) | 1.79554096 |
| 128 | Hemangiomatosis (HP:0007461) | 1.79088483 |
| 129 | Advanced eruption of teeth (HP:0006288) | 1.78911921 |
| 130 | Renal cell carcinoma (HP:0005584) | 1.77865079 |
| 131 | Stroke (HP:0001297) | 1.77663069 |
| 132 | Ulnar deviation of the wrist (HP:0003049) | 1.77548669 |
| 133 | Broad thumb (HP:0011304) | 1.77449588 |
| 134 | Muscle stiffness (HP:0003552) | 1.77168501 |
| 135 | Scapular winging (HP:0003691) | 1.76897618 |
| 136 | Thin ribs (HP:0000883) | 1.76432755 |
| 137 | Hyperparathyroidism (HP:0000843) | 1.76234750 |
| 138 | Slender build (HP:0001533) | 1.75747321 |
| 139 | Thin bony cortex (HP:0002753) | 1.75193303 |
| 140 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.74678394 |
| 141 | Lipoatrophy (HP:0100578) | 1.73938461 |
| 142 | Prolonged partial thromboplastin time (HP:0003645) | 1.73619507 |
| 143 | Dilatation of the ascending aorta (HP:0005111) | 1.72678187 |
| 144 | Precocious puberty (HP:0000826) | 1.72296033 |
| 145 | Cholelithiasis (HP:0001081) | 1.72213927 |
| 146 | Gout (HP:0001997) | 1.71401219 |
| 147 | Cerebral inclusion bodies (HP:0100314) | 1.71081876 |
| 148 | Hydroxyprolinuria (HP:0003080) | 1.70879439 |
| 149 | Abnormality of proline metabolism (HP:0010907) | 1.70879439 |
| 150 | Neonatal death (HP:0003811) | 1.70648561 |
| 151 | Preauricular pit (HP:0004467) | 1.70411659 |
| 152 | Periauricular skin pits (HP:0100277) | 1.70411659 |
| 153 | Acanthosis nigricans (HP:0000956) | 1.69969655 |
| 154 | Distal lower limb amyotrophy (HP:0008944) | 1.69079690 |
| 155 | Vascular calcification (HP:0004934) | 1.68910288 |
| 156 | Abnormal gallbladder physiology (HP:0012438) | 1.68716518 |
| 157 | Cholecystitis (HP:0001082) | 1.68716518 |
| 158 | Bladder diverticulum (HP:0000015) | 1.68184467 |
| 159 | Wide anterior fontanel (HP:0000260) | 1.68129334 |
| 160 | Coxa vara (HP:0002812) | 1.67921127 |
| 161 | Hyperextensible skin (HP:0000974) | 1.67444785 |
| 162 | Fatigue (HP:0012378) | 1.67040762 |
| 163 | Congenital hip dislocation (HP:0001374) | 1.65793069 |
| 164 | Narrow palate (HP:0000189) | 1.64994599 |
| 165 | Popliteal pterygium (HP:0009756) | 1.63245420 |
| 166 | Flexion contracture of toe (HP:0005830) | 1.61508439 |
| 167 | Joint contractures involving the joints of the feet (HP:0100492) | 1.61508439 |
| 168 | Aplasia involving bones of the extremities (HP:0009825) | 1.60696278 |
| 169 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.60696278 |
| 170 | Aplasia of the phalanges of the hand (HP:0009802) | 1.60696278 |
| 171 | Leiomyosarcoma (HP:0100243) | 1.60278265 |
| 172 | Uterine leiomyosarcoma (HP:0002891) | 1.60278265 |
| 173 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.59556951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.92900543 |
| 2 | STK24 | 3.97698436 |
| 3 | ERN1 | 3.00674580 |
| 4 | TTN | 2.87499592 |
| 5 | PKN2 | 2.87491392 |
| 6 | RIPK1 | 2.78851717 |
| 7 | PRPF4B | 2.70230973 |
| 8 | EPHB2 | 2.57544622 |
| 9 | ICK | 2.55749010 |
| 10 | PDGFRA | 2.04520298 |
| 11 | SIK1 | 2.03736625 |
| 12 | BCKDK | 1.96792934 |
| 13 | MAP3K10 | 1.90306126 |
| 14 | PTK6 | 1.85449035 |
| 15 | IRAK3 | 1.85282146 |
| 16 | DDR2 | 1.82817124 |
| 17 | LATS1 | 1.79597091 |
| 18 | JAK3 | 1.77938837 |
| 19 | PRKD3 | 1.76123386 |
| 20 | FGFR4 | 1.75390866 |
| 21 | LMTK2 | 1.74519715 |
| 22 | PDK4 | 1.71906856 |
| 23 | PDK3 | 1.71906856 |
| 24 | LATS2 | 1.65151265 |
| 25 | TYRO3 | 1.60376957 |
| 26 | EPHB1 | 1.59076436 |
| 27 | SMG1 | 1.58855149 |
| 28 | PHKG2 | 1.55664219 |
| 29 | PHKG1 | 1.55664219 |
| 30 | DMPK | 1.48098332 |
| 31 | CDK12 | 1.44307331 |
| 32 | KSR2 | 1.37165244 |
| 33 | BMX | 1.35981044 |
| 34 | TESK1 | 1.31430406 |
| 35 | RPS6KA2 | 1.31382319 |
| 36 | RPS6KC1 | 1.30558684 |
| 37 | RPS6KL1 | 1.30558684 |
| 38 | CCNB1 | 1.30094490 |
| 39 | EEF2K | 1.24369991 |
| 40 | TAOK3 | 1.23681415 |
| 41 | PTK2B | 1.13597903 |
| 42 | PTK2 | 1.10614106 |
| 43 | TAOK1 | 1.09817562 |
| 44 | MARK2 | 1.09472543 |
| 45 | RPS6KA6 | 1.09360840 |
| 46 | DYRK1B | 1.08032265 |
| 47 | LRRK2 | 1.06567463 |
| 48 | CAMK1G | 1.06099784 |
| 49 | PAK3 | 1.05827314 |
| 50 | FGFR2 | 1.05212296 |
| 51 | RIPK4 | 1.01253474 |
| 52 | RET | 1.00475258 |
| 53 | WNK4 | 1.00087521 |
| 54 | ILK | 0.95537956 |
| 55 | TAOK2 | 0.95480404 |
| 56 | TGFBR2 | 0.95464942 |
| 57 | PDK2 | 0.94412533 |
| 58 | CDC42BPA | 0.93514640 |
| 59 | PAK6 | 0.93010670 |
| 60 | MAPKAPK3 | 0.92522023 |
| 61 | CAMK1D | 0.90550451 |
| 62 | PAK4 | 0.88709749 |
| 63 | CAMK4 | 0.87523923 |
| 64 | MST1R | 0.87419253 |
| 65 | MET | 0.85374176 |
| 66 | MTOR | 0.84259543 |
| 67 | PRKD1 | 0.81388680 |
| 68 | PRKD2 | 0.80480663 |
| 69 | NTRK1 | 0.79941409 |
| 70 | SGK3 | 0.79905242 |
| 71 | ZAP70 | 0.79830854 |
| 72 | OBSCN | 0.79532721 |
| 73 | FER | 0.79445828 |
| 74 | PAK2 | 0.77850996 |
| 75 | PINK1 | 0.77565828 |
| 76 | MAP3K13 | 0.76774168 |
| 77 | PDGFRB | 0.75865321 |
| 78 | TRPM7 | 0.75733719 |
| 79 | SIK2 | 0.73683542 |
| 80 | TIE1 | 0.73461430 |
| 81 | CAMK1 | 0.73102756 |
| 82 | MAP3K7 | 0.72982938 |
| 83 | PDPK1 | 0.72846299 |
| 84 | NTRK2 | 0.71710799 |
| 85 | EPHA2 | 0.70040242 |
| 86 | MAPK12 | 0.68944156 |
| 87 | ARAF | 0.68072152 |
| 88 | MAP2K1 | 0.67430489 |
| 89 | IRAK4 | 0.65118432 |
| 90 | MAP3K6 | 0.64798424 |
| 91 | MAP2K3 | 0.64675501 |
| 92 | MAP3K2 | 0.64289557 |
| 93 | ROCK1 | 0.64064276 |
| 94 | MAP3K11 | 0.62871496 |
| 95 | MYLK | 0.62598034 |
| 96 | STK39 | 0.61788502 |
| 97 | STK38 | 0.60942338 |
| 98 | MAP3K9 | 0.60916592 |
| 99 | FGFR3 | 0.60009079 |
| 100 | MAP2K2 | 0.59774753 |
| 101 | HIPK2 | 0.58892401 |
| 102 | MAP3K3 | 0.58311910 |
| 103 | CAMKK1 | 0.58138782 |
| 104 | HCK | 0.57195018 |
| 105 | FGFR1 | 0.56780322 |
| 106 | CDK6 | 0.56709217 |
| 107 | PRKCH | 0.56694827 |
| 108 | EPHA3 | 0.55979045 |
| 109 | GSK3A | 0.55871542 |
| 110 | ERBB2 | 0.55657761 |
| 111 | TBK1 | 0.55449840 |
| 112 | PRKAA2 | 0.55280530 |
| 113 | MAP3K1 | 0.54607581 |
| 114 | TYK2 | 0.53777954 |
| 115 | WNK1 | 0.52609022 |
| 116 | CSK | 0.52605386 |
| 117 | MAP2K4 | 0.52138088 |
| 118 | PRKAA1 | 0.50916999 |
| 119 | NEK9 | 0.50432334 |
| 120 | PDK1 | 0.48176323 |
| 121 | TNK2 | 0.47978291 |
| 122 | SIK3 | 0.47375684 |
| 123 | MOS | 0.46489745 |
| 124 | JAK1 | 0.46127216 |
| 125 | DAPK3 | 0.45418209 |
| 126 | JAK2 | 0.44702944 |
| 127 | CDK9 | 0.42089924 |
| 128 | MAPK11 | 0.40482535 |
| 129 | STK3 | 0.40177567 |
| 130 | KSR1 | 0.40013233 |
| 131 | ERBB4 | 0.39856094 |
| 132 | LIMK1 | 0.39796697 |
| 133 | STK11 | 0.38241586 |
| 134 | SGK494 | 0.37230523 |
| 135 | SGK223 | 0.37230523 |
| 136 | PRKG2 | 0.36659005 |
| 137 | PRKCZ | 0.36460035 |
| 138 | DAPK2 | 0.36367621 |
| 139 | KDR | 0.36248830 |
| 140 | ROCK2 | 0.35836234 |
| 141 | PIK3CG | 0.35613897 |
| 142 | SGK2 | 0.34062727 |
| 143 | IRAK2 | 0.33896287 |
| 144 | MAPKAPK2 | 0.31683770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.57494522 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.88228303 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.54589537 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48395432 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.38597167 |
| 6 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.29881297 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.14172192 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.08917138 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.07485292 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.02575597 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.94269459 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.90187088 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.85480355 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.83936613 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.83793543 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.75345275 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59208406 |
| 18 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.53574728 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.52346452 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.49485547 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.48818085 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46974033 |
| 23 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.45203136 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.44008155 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43487613 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43408013 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.38569067 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.36112214 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.34729567 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31095766 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29783250 |
| 32 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.29507546 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.29324927 |
| 34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.27228968 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.23453980 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22932062 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.20063864 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19576897 |
| 39 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.13224165 |
| 40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.12717015 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.11544132 |
| 42 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.10771837 |
| 43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.09846890 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.09502010 |
| 45 | Endocytosis_Homo sapiens_hsa04144 | 1.03988513 |
| 46 | Insulin resistance_Homo sapiens_hsa04931 | 1.03441474 |
| 47 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.02144985 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99793205 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.99311556 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97979519 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97506088 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97161020 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.96313624 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.96275248 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94423288 |
| 56 | Thyroid cancer_Homo sapiens_hsa05216 | 0.93552033 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92590578 |
| 58 | Malaria_Homo sapiens_hsa05144 | 0.92326301 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92100420 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91615232 |
| 61 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90830783 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90614660 |
| 63 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89260246 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.88191521 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.87969549 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87278604 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87082822 |
| 68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86738757 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85436664 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84792351 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84660729 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84552098 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84105325 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.83380598 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.83331646 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82784250 |
| 77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.82227057 |
| 78 | Prostate cancer_Homo sapiens_hsa05215 | 0.81292648 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.80663617 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.80500461 |
| 81 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.79548061 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79484273 |
| 83 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.78979348 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.78886231 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78036890 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77373078 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.76947864 |
| 88 | Tuberculosis_Homo sapiens_hsa05152 | 0.76782717 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.76661493 |
| 90 | Long-term potentiation_Homo sapiens_hsa04720 | 0.75806368 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75790465 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75448795 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.75412469 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75407332 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.73859721 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.73484941 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.73367262 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72829993 |
| 99 | Lysosome_Homo sapiens_hsa04142 | 0.72479623 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.71570691 |
| 101 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70393873 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70303951 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69809717 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69764850 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69653787 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.68284850 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67652175 |
| 108 | Axon guidance_Homo sapiens_hsa04360 | 0.66942802 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65280264 |
| 110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64953287 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.63700718 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62859603 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.62486121 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61269295 |
| 115 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.61129734 |
| 116 | Long-term depression_Homo sapiens_hsa04730 | 0.61084948 |
| 117 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.61049909 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60915990 |
| 119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60675969 |
| 120 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60670823 |
| 121 | Melanogenesis_Homo sapiens_hsa04916 | 0.60342892 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59661326 |
| 123 | Influenza A_Homo sapiens_hsa05164 | 0.58695614 |
| 124 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58489680 |
| 125 | Measles_Homo sapiens_hsa05162 | 0.57098101 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57092086 |
| 127 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57070411 |
| 128 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56817801 |
| 129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56743035 |
| 130 | Apoptosis_Homo sapiens_hsa04210 | 0.56661897 |
| 131 | ABC transporters_Homo sapiens_hsa02010 | 0.54719616 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53921712 |
| 133 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52483231 |
| 134 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50453418 |
| 135 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50320956 |
| 136 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.49500392 |
| 137 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48219767 |
| 138 | Tight junction_Homo sapiens_hsa04530 | 0.47394352 |
| 139 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45720830 |
| 140 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45142643 |
| 141 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.39111515 |
| 142 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.38898840 |
| 143 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38780753 |
| 144 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.38088995 |
| 145 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37478027 |
| 146 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36533786 |
| 147 | Glioma_Homo sapiens_hsa05214 | 0.36403628 |
| 148 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36184042 |
| 149 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.35609930 |
| 150 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.34823198 |
| 151 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34681412 |
| 152 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34577358 |
| 153 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.34319407 |
| 154 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33290458 |
| 155 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.32929454 |
| 156 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32902730 |
| 157 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.32525307 |
| 158 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30705139 |
| 159 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29739739 |
| 160 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29527229 |

